News
12-13-2012, 05:21 AM
Veridex, LLC today announced approval from the China State Food & Drug Administration (SFDA) for the CellSearch circulating tumor cell (CTC) test as an in vitro diagnostic for women with metastatic breast cancer.
More... (http://www.news-medical.net/news/20121213/China-SFDA-approves-Veridexe28099s-CellSearch-test-for-women-with-metastatic-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20121213/China-SFDA-approves-Veridexe28099s-CellSearch-test-for-women-with-metastatic-breast-cancer.aspx)